EQIPP: ADHD - Diagnose, Treat, and Monitor / online course
This course helps guide primary care clinicians (PCCs) in the evidence-based processes for diagnosing, treating, and monitoring of children and adolescents with ADHD. It provides practical ways to measure and improve the quality of ADHD care delivery.
ADHD - Diagnose, Treat, and Monitor.docx
Microsoft Word Dokument
14.6 KB
ADHD in adults: what it’s like living with the condition – and why many still struggle to get diagnosed
Many of us think of ADHD (attention deficit hyperactivity disorder) as a childhood condition – which is typically when it’s diagnosed. But a growing number of people are sharing their experiences of being diagnosed with ADHD in adulthood. Social media has even played a role in this, with reports of people going to see their doctor after first learning about symptoms on TikTok. In fact, around 2.5% of adults are thought to live with ADHD – including us.
Yet despite this growing awareness, many adults continue to struggle to get a diagnosis.
ADHD in adults.docx
Microsoft Word Dokument
52.1 KB
International Consensus Statement that cogently summarizes the highest quality, evidenced-based assertions we can make about ADHD. (soon to be
published)
WFADHD, 04.2020
https://drive.google.com/file/d/1teQKJnWsPhnORsFkZ7GvT9v_Yryu7tf8/view?usp=sharing
https://drive.google.com/file/d/1FQYbq4ddNxmV0cvM0t5Wt_COzl0PMqYc/view?usp=sharing
This paper will be published as an open access paper with the hope that
it will be disseminated widely to reduce stigma, correct misconceptions and educate the world about the disorder.
The effects of stimulant dose and dosing strategy on treatment outcomes in attention-deficit/hyperactivity disorder in children and adolescents: a meta-analysis
Clinical guidelines currently recommend practitioners titrate stimulant medications, i.e., methylphenidate (MPH) and amphetamines (AMP), to the dose that maximizes symptom control without eliciting intolerable adverse events (AEs) when treating attention-deficit/hyperactivity disorder (ADHD) in school-aged children/adolescents.
The effects of stimulant dose and dosing
Microsoft Word Dokument
90.0 KB
Prof. Yamalis Diaz Ph.D.:
So happy to join executive producer, Nancy Armstrong, and the #CBSMornings team to
help launch the incredible new ADHD documentary, #TheDisruptors. I and several other ADHD experts share our thoughts from a clinical perspective, and the families and celebrities with ADHD highlight
the lived experience.
The documentary does a great job of highlighting both the challenges *and* the strengths of the ADHD brain and will help reduce the stigma and misunderstandings about ADHD.
https://www.cbsnews.com/video/new-documentary-aims-to-educate-reframe-view-of-adhd/#x